glp-1 and type 1 diabetes In patients with residual ß-cell function, treatment GLP-1 Agonists - What is
Description
Regulation of high mobility group box 1 and hypoxia in the migration of mesenchymal stem cells
[DOI] [PubMed] [Google Scholar] Mann R
The best choice for you will depend on your lifestyle and preferences
The researchers note that further studies are needed to determine the causality between the drug and the increased incidence of NAION
What tests or monitoring are needed while on GLP-1 medications
Please refer to the current version for up-to-date recommendations
